Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Genius Sports Limited (NYSE: GENI) closed at $11.95 in the last session, up 0.08% from day before closing price of $11.94. In other words, the price has increased by $0.08 from its previous closing price. On the day, 5.19 million shares were traded. GENI stock price reached its highest trading level at $12.2 during the session, while it also had its lowest trading level at $11.89.
Ratios:
We take a closer look at GENI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 80.30. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Roth Capital on September 12, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On July 25, 2025, Northland Capital started tracking the stock assigning a Outperform rating and target price of $14.
On July 09, 2025, Arete started tracking the stock assigning a Buy rating and target price of $15.Arete initiated its Buy rating on July 09, 2025, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 25 ’25 when Bradley Kimberly Williams bought 14,999 shares for $12.97 per share.
Burns Daniel Paul bought 8,157 shares of GENI for $85,222 on May 13 ’25. On Mar 06 ’25, another insider, Stevens Eric, who serves as the Officer of the company, bought 79,373 shares for $9.38 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2849372416 and an Enterprise Value of 2658385664. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.41 while its Price-to-Book (P/B) ratio in mrq is 3.96. Its current Enterprise Value per Revenue stands at 4.76 whereas that against EBITDA is -33.482.
Stock Price History:
The Beta on a monthly basis for GENI is 1.86, which has changed by 0.6392318 over the last 52 weeks, in comparison to a change of 0.17904854 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $13.73, while it has fallen to a 52-week low of $6.72. The 50-Day Moving Average of the stock is -4.02%, while the 200-Day Moving Average is calculated to be 15.20%.
Shares Statistics:
According to the various share statistics, GENI traded on average about 5.25M shares per day over the past 3-months and 5354430 shares per day over the past 10 days. A total of 238.44M shares are outstanding, with a floating share count of 217.97M. Insiders hold about 8.59% of the company’s shares, while institutions hold 93.73% stake in the company. Shares short for GENI as of 1757894400 were 24486280 with a Short Ratio of 4.66, compared to 1755216000 on 27808198. Therefore, it implies a Short% of Shares Outstanding of 24486280 and a Short% of Float of 11.229999.
Earnings Estimates
Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is $0.12, with high estimates of $0.12 and low estimates of $0.12.
Analysts are recommending an EPS of between $0.3 and $0.3 for the fiscal current year, implying an average EPS of $0.3. EPS for the following year is $0.41, with 1.0 analysts recommending between $0.41 and $0.41.
Revenue Estimates
According to 17 analysts,. The current quarter’s revenue is expected to be $156.23M. It ranges from a high estimate of $161M to a low estimate of $136.08M. As of. The current estimate, Genius Sports Limited’s year-ago sales were $120.2MFor the next quarter, 17 analysts are estimating revenue of $226.18M. There is a high estimate of $246.18M for the next quarter, whereas the lowest estimate is $222.5M.
A total of 17 analysts have provided revenue estimates for GENI’s current fiscal year. The highest revenue estimate was $649.5M, while the lowest revenue estimate was $641.4M, resulting in an average revenue estimate of $645.14M. In the same quarter a year ago, actual revenue was $510.89MBased on 18 analysts’ estimates, the company’s revenue will be $754.61M in the next fiscal year. The high estimate is $772.6M and the low estimate is $729M.
